An experience of use of canakinumab IL-1 inhibitor in children with cryopyrin-associated periodic syndromes (CAPS)

Antzeko izenburuak

• The interleukin 1 inhibitor canakinumab in the treatment of cryopyrin-associated periodic syndromes (CAPS): clinical experience
  nork: Svetlana Olegovna Salugina, et al.
  Argitaratua: (2014-12-01)
• The interleukin 1 inhibitor canakinumab in the treatment of cryopyrin-associated periodic syndromes (CAPS): clinical experience
  nork: Svetlana Olegovna Salugina, et al.
  Argitaratua: (2014-12-01)
• Cryopyrin-associated periodic syndromes (CAPS): report on two cases (Muckle-Wells syndrome (MWS) and CINCA/NOMID)
  nork: Salugina, SO, et al.
  Argitaratua: (2011)
• PReS-FINAL-2241: Cases of cryopyrin-associated periodic syndromes (CAPS) in one single rheumatologic center of Russia
  nork: Salugina, SO, et al.
  Argitaratua: (2013)
• Current approaches to diagnosis, treatment, and monitoring in patients with cryopyrin-associated periodic syndromes (CAPS)
  nork: S. O. Salugina, et al.
  Argitaratua: (2016-06-01)